Summary of findings: liposomal bupivacaine vs bupivacaine
Incidence of adverse events within 30 days of surgery · aged 18 years and older undergoing elective surgery at any surgical site
1 finding from 1 review
- Liposomal bupivacaine infiltration at the surgical site for the management of postoperative pain 2017 · Cochrane Headline outcomes onlyno estimate extracted3 studies · 583 participantsModerate